App database

IntoxiVet

Thomas Grenier

Store data observed · From public App Store data · How we score apps

  • Medical
  • App Store
  • United States
  • —0 ratings
  • Paid $0.99
  • Updated
  • Observed

Ratings

Observed
0

Chart position

Observed
—Not on the top charts

90-day growth

—not enough history yet

Opportunity score

AI-derived
13/100Weak · low confidence
Own IntoxiVet? Share your real numbers

Your numbers stay private. They only tune MRRBeam's estimates, so every app's figures get more accurate.

Sign in to share them.

Made IntoxiVet? Add a “Tracked in Medical” badge to your site
Tracked in Medical badge

About IntoxiVetObserved

IntoxiVet is a Medical app by Thomas Grenier on the United States App Store. Released May 17, 2020; last updated Sep 11, 2023 (version 1.5). IntoxiVet costs $0.99 to download.

MRRBeam rates the success of IntoxiVet 0/100 (early stage).

IntoxiVet est une application destinée aux propriétaires d'animaux de compagnie. De nombreux produits sont toxiques pour nos compagnons et il est important de les connaître pour les protéger au mieux.
From the App Store listing
Success score
0/100 Early stage
In Medical
Outside the top 100
Chart position
Not on the top charts
Loading the full report…

IntoxiVet: common questions

What is IntoxiVet?
IntoxiVet is a Medical app developed by Thomas Grenier, available on the App Store. It was first released on May 17, 2020.
How much does IntoxiVet cost?
IntoxiVet costs $0.99 to download.
Is IntoxiVet successful?
MRRBeam rates the success of IntoxiVet 0/100 (early stage). The success score combines rating volume, chart position and average rating.
When was IntoxiVet last updated?
IntoxiVet was last updated on Sep 11, 2023 (version 1.5).
What are alternatives to IntoxiVet?
Similar Medical apps tracked by MRRBeam include CVS Health, MyChart, healow, UnitedHealthcare and GoodRx: Prescription Savings.
Is there room to build a competitor to IntoxiVet?
MRRBeam's opportunity score for IntoxiVet is 13/100. Limited opening: an older app, little observable demand and low price points.